The Treg/PD1-CD8+ T cell distance ratio from cancer cells was significantly smaller for the recur group than for the non-recur group, by 0.55-fold (p = 0.048) (Figure 4E and Supplementary Table S6). This evidence concerns the gene CD8A and cancer.